Crossmark

HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome

Published Online: 2022-03-30

Published Print: 2022-06

Authors

Skenderi, Faruk

Alahmad, Mohamad Alhoda Mohamad

Tahirovic, Emin

Alahmad, Yaman M.

Gatalica, Zoran

Vranic, Semir https://orcid.org/0000-0001-9743-7265
Funding

Funding for this research was provided by:

Qatar University
License Information

Text and Data Mining valid from 2022-03-30

Version of Record valid from 2022-03-30
More Information

Article History

Received: 5 February 2022

Accepted: 17 March 2022

First Online: 30 March 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: Ethical approval is not required as the SEER database is a publicly available database with anonymized patients’ data. The corresponding author signed a SEER Research Data Agreement to use the data for research purposes.

: Not applicable.

Document is current